115478, Moscow, Kashirskoe highway 23

Unique Technologies Clinic «NeuroVita»

  • Ultra early molecular-biological diagnostics of the diseases of civilization
  • Innovation in neurology
  • Innovation in neurology
  • Ultra early molecular-biological diagnostics of the diseases of civilization
    Ultra early molecular-biological diagnostics of the diseases of civilization

    More

  • Innovation in neurology
    Ultra early molecular-biological diagnostics of the diseases of civilization

    More

  • Innovation in neurology
    Innovative approach to human longevity!

    More

Ultra early molecular-biological diagnostics of the diseases of civilization

In the past five years, Prof. Andrey Bryukhovetskiy and his team made several discoveries of the post-genomic and regenerative medicine and made a breakthrough in the development of the unique post-genomic biotechnology of extremely early molecular-biological diagnostics of the range of the fatal diseases of civilization such as cancer and other malignancies, neurodegenerative diseases like Alzheimer’s and Parkinson’s disease, amyotrophic lateral sclerosis and autoimmune diseases.

The research of our scientists is the first in the world that established the fundamental universal mechanism of the proteomic damage of the HCS by the horizontal and vertical protein exchange through the microvesicular transport. This mechanism explains for the reasons of not only the malignant disorders but also of the autoimmune and neurodegenerative diseases. The experiments of the Russian scientists in vitro and in vivo show that the main age-related diseases of aggregation are the variety of the post-genome disease of the human HSC, and not the diseases of the damaged specialized cells (neural, pancreatic, of connective tissue). The HSCs in the human body are the key tool of the recovery and regulation, so when we restore its molecular protein structure, we restore the natural biological basis of the self-management and self-regulation.

The membrane protein of the HSC surface have been studied in 200 adult cancer cases and 250 children cancer cases and compared to the data of 52 healthy subjects. Mapping and profiling of the HSC membrane proteins help detect disease-specific protein profiles on the HSC membrane surface. Thus, we are able to diagnose malignant disorders at a very early stage of disease when the tumor markers are not detectable yet as the molecular signs of degeneration and clinical symptoms are absent. Similar data have been received for the range of autoimmune and neurodegenerative disorders (Bryukhovetskiy AS, Grivtsova LY, 2019).

The technology permits detection of the various types of malignancies, autoimmune (such as type 1 diabetes, systemic lupus erythematosus, multiple sclerosis, rheumatoid arthritis, autoimmune thyroiditis, polymyositis and other) and neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease, senile dementia, amyotrophic lateral sclerosis and other) at the earliest possible stage. Extremely early diagnostics permits detection of the disease in the bud, eliminate it and prevent relapses (Bryukhovetskiy A.S.,2019).

The work of Professor Bryukhovetskiy and his team is at the frontiers of contemporary research. His works in the sphere of exosomal transport and immunotherapy of cancer are pioneering and ahead of the time.

In our clinic we isolate your cells and check them for the signs of mortal diseases. Your own healthy stem cells can extend your life by 30 to 40 years and save you from the onset and relapse of the fatal diseases of civilization!

  • Thank you for visiting our webpage!
  • Thank you for visiting our webpage!

    Thank you for visiting our webpage!

    Today cancer cannot be cured completely, but it can be transferred into a chronic and non-lethal disease, the survival rates can be significantly increased and the life quality can be improved. Alternatively, we can help provide a dignified departure from life, free from pain and humiliation.

    Sincerely yours, Professor, PhD, MD
    Andrey S. Bryukhovetskiy